Guardado en:
| Autores principales: | Vaisak O. Nair, Zachary A. Yetmar, Bismarck S. Bisono‐Garcia, Lisa Brumble, Holenarasipur R. Vikram, Raymund R. Razonable, Elena Beam |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70342 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
por: Abdallah Mughrabi, et al.
Publicado: (2026)
por: Abdallah Mughrabi, et al.
Publicado: (2026)
Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2024)
por: Chia‐Yu Chiu, et al.
Publicado: (2024)
Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2025)
por: Chia‐Yu Chiu, et al.
Publicado: (2025)
Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors
por: Chia‐Yu Chiu, et al.
Publicado: (2024)
por: Chia‐Yu Chiu, et al.
Publicado: (2024)
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)
por: Lemuel R. Non, et al.
Publicado: (2024)
Surgical Site Infection After Intestine Transplantation: Risk Factors and Outcomes
por: Mayyadah H. Alabdely, et al.
Publicado: (2025)
por: Mayyadah H. Alabdely, et al.
Publicado: (2025)
Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients
por: Paavana Varanasi, et al.
Publicado: (2026)
por: Paavana Varanasi, et al.
Publicado: (2026)
Impact of Early Rejection Treatment on Infection Development in Kidney Transplant Recipients: A Propensity Analysis
por: Simran Gupta, et al.
Publicado: (2024)
por: Simran Gupta, et al.
Publicado: (2024)
Confronting the Challenges of Prevention, Diagnosis, and Management of Donor‐Derived Coccidioidomycosis
por: Holenarasipur R. Vikram
Publicado: (2024)
por: Holenarasipur R. Vikram
Publicado: (2024)
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
por: Majd Alsoubani, et al.
Publicado: (2025)
por: Majd Alsoubani, et al.
Publicado: (2025)
Clinical Characteristics and Outcomes of Pneumocystis Pneumonia in Solid Organ Transplant Recipients
por: Aaron M. Pulsipher, et al.
Publicado: (2026)
por: Aaron M. Pulsipher, et al.
Publicado: (2026)
Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
por: John‐Anthony Coppola, et al.
Publicado: (2025)
por: John‐Anthony Coppola, et al.
Publicado: (2025)
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
por: Hanna L. Kleiboeker, et al.
Publicado: (2025)
Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
por: Margarita A. Peradejordi Lastras
Publicado: (2016)
Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
por: Natasha Banga, et al.
Publicado: (2025)
por: Natasha Banga, et al.
Publicado: (2025)
Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
por: Ye In Christopher Kwon, et al.
Publicado: (2026)
por: Ye In Christopher Kwon, et al.
Publicado: (2026)
Lung Transplant Outcomes Following Treatment of Pre‐Transplant MAC Pulmonary Infection
por: Prasanth Balasubramanian, et al.
Publicado: (2025)
por: Prasanth Balasubramanian, et al.
Publicado: (2025)
Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study
por: Rasha El‐Rifai, et al.
Publicado: (2026)
por: Rasha El‐Rifai, et al.
Publicado: (2026)
Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
por: Maria Alejandra Mendoza, et al.
Publicado: (2024)
por: Maria Alejandra Mendoza, et al.
Publicado: (2024)
Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
por: Yeahwa Hong, et al.
Publicado: (2024)
por: Yeahwa Hong, et al.
Publicado: (2024)
A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
por: Afolarin A. Otunla, et al.
Publicado: (2026)
por: Afolarin A. Otunla, et al.
Publicado: (2026)
Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
por: Lien‐Chung Wei, et al.
Publicado: (2025)
por: Lien‐Chung Wei, et al.
Publicado: (2025)
Incidence and Risk Factors of Obesity and Overweight in Kidney Transplant Recipients and Their Effect on Graft Outcome
por: Muhammad Abdul Mabood Khalil, et al.
Publicado: (2025)
por: Muhammad Abdul Mabood Khalil, et al.
Publicado: (2025)
Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
por: Madeleine R. Heldman, et al.
Publicado: (2024)
por: Madeleine R. Heldman, et al.
Publicado: (2024)
Premature Discontinuation of Trimethoprim/Sulfamethoxazole Prophylaxis in Abdominal Transplant Recipients: A Deeper Dive
por: Madeline R. Hudson, et al.
Publicado: (2025)
por: Madeline R. Hudson, et al.
Publicado: (2025)
Efficacy of a Single Dose of Intravesical Aminoglycoside for the Prevention of Urinary Tract Infections in Kidney Transplant Recipients
por: Sarah Dean, et al.
Publicado: (2026)
por: Sarah Dean, et al.
Publicado: (2026)
Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
por: David Moynan, et al.
Publicado: (2024)
por: David Moynan, et al.
Publicado: (2024)
The Clinical Impact of Antibiotic Allergy Labels on One‐Year Outcomes of Solid Organ Transplant Recipients
por: Sashi Niranjan Nair, et al.
Publicado: (2026)
por: Sashi Niranjan Nair, et al.
Publicado: (2026)
Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
por: Meagan O. Rogers, et al.
Publicado: (2024)
por: Meagan O. Rogers, et al.
Publicado: (2024)
A DOOR to Defining New Outcomes for Research in Transplant Recipients’ Infections
por: Francesco Cogliati Dezza, et al.
Publicado: (2026)
por: Francesco Cogliati Dezza, et al.
Publicado: (2026)
Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
por: Ana Khazan, et al.
Publicado: (2026)
por: Ana Khazan, et al.
Publicado: (2026)
Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
por: Iris Feng, et al.
Publicado: (2025)
por: Iris Feng, et al.
Publicado: (2025)
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Marilyne Daher, et al.
Publicado: (2025)
por: Marilyne Daher, et al.
Publicado: (2025)
Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
por: Madhumita Rao, et al.
Publicado: (2025)
por: Madhumita Rao, et al.
Publicado: (2025)
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
por: Madeleine R. Heldman, et al.
Publicado: (2024)
por: Madeleine R. Heldman, et al.
Publicado: (2024)
Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era
por: Lana Hasan, et al.
Publicado: (2025)
por: Lana Hasan, et al.
Publicado: (2025)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
por: Eishan Ashwat, et al.
Publicado: (2025)
por: Eishan Ashwat, et al.
Publicado: (2025)
Infection Prevention and Surveillance in the Care of Australasian Solid‐Organ Transplant Recipients
por: Priya Garg, et al.
Publicado: (2025)
por: Priya Garg, et al.
Publicado: (2025)
Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
por: Avery Marcotte, et al.
Publicado: (2025)
por: Avery Marcotte, et al.
Publicado: (2025)
Characteristics and Clinical Outcomes of Postoperative Pleural Space Infections Among Lung Transplant Recipients
por: Miranda Arzate, et al.
Publicado: (2026)
por: Miranda Arzate, et al.
Publicado: (2026)
Ejemplares similares
-
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
por: Abdallah Mughrabi, et al.
Publicado: (2026) -
Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2024) -
Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients
por: Chia‐Yu Chiu, et al.
Publicado: (2025) -
Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors
por: Chia‐Yu Chiu, et al.
Publicado: (2024) -
Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
por: Lemuel R. Non, et al.
Publicado: (2024)